Cremophor is a polyoxyethylated castor oil intended as an inert vehicl
e for delivery of lipophilic drugs including taxol, a promising antica
ncer drug. Cremophor has been implicated in some undesirable side effe
cts, e.g., hypersensitivity reactions which nearly resulted in prematu
re termination of taxol phase I clinical trials. We have shown previou
sly that clinical concentrations of purified taxol inhibit steroid sec
retion by cultured granulosa cells. Since cremophor has also been show
n to effect steroidogenic pathways, dose-response studies were conduct
ed for both agents, and the ability of taxol- or cremophor-pretreated
cells to produce progesterone was also investigated. Porcine granulosa
cells were treated with therapeutic and subtherapeutic concentrations
of cremophor (11-883 mu g/ well) or of taxol (0.123-10 mu g/well) for
24 h. A high concentration of cremophor, equivalent to that present i
n a clinical dose of taxol, induced drastic morphologic alterations in
granulosa cells and abolished progesterone production, while a low do
se enhanced progesterone production. Likewise, high doses of taxol sup
pressed, while low doses stimulated progesterone output, presumably th
rough separate mechanisms. These results show that therapeutic doses o
f both agents irreversibly suppress granulosa cell function, while low
concentrations of both are potent stimulators of progesterone product
ion.